Baird analyst Jonathan Komp maintains Peloton Interactive (NASDAQ:PTON) with a Outperform and lowers the price target from $25 to $20.
HC Wainwright & Co. Maintains Buy on Outlook Therapeutics, Maintains $5 Price Target
HC Wainwright & Co. analyst Douglas Tsao maintains Outlook Therapeutics (NASDAQ:OTLK) with a Buy and maintains $5 price target.